Immune systemAcute respiratory distress syndromeHyperinflammationCytokine stormAim Coronavirus disease 2019 (COVID-19) is a novel highly contagious infection caused by SARS-CoV-2, which has been became a global public health challenge. The pathogenesis of this virus is not yet clearly understood, but...
The aging of the immune system. Transpl. Int. 22, 1041–1050 (2009). Article CAS PubMed Google Scholar Nikolich-Zugich, J. et al. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. GeroScience 42, 505–514 (2020). ...
We review evidence that variability in innate immune system components among humans is a main contributor to the heterogeneous disease courses observed for coronavirus disease 2019 (COVID-19), the disease spectrum induced by SARS-CoV-2. A better understanding of the pathophysiological mechanisms ...
as well as an “exaggerated” response by the immune system in long COVID sufferers to the COVID virus itself. Some of the levels of circulating immune system cell types were increased while others were decreased
A study by Stanford University of Medicine and other institutions suggests that immunological differences in the innate immune system may contribute to the varying severity of COVID-19 cases. Some people get really sick fromCOVID-19, and others don’t. Nobody knows why. ...
Dysregulated immune responses against the SARS-CoV-2 virus are instrumental in severe COVID-19. However, the immune signatures associated with immunopathology are poorly understood. Here we use multi-omics single-cell analysis to probe the dynamic immune
interest as it is the part of our blood that contains crucial information about our immune system. Analysis of the serum made it possible to create a detailed timeline of the level of ‘neutralizing antibodies’ produced against COVID-19 infection, and so to see if there was long-term ...
a population of T cells that are armed and ready to protect you, you could control the infection better than someone who doesn’t have those cross-reactive cells,” says Marion Pepper, an immunologist at the University of Washington who is studying the immune responses of ...
In the mouse model of COVID-19, researchers were able to rescue infected mice from pneumonia by blocking the NLPR3 inflammasome pathway. With the inflammasome pathway blocked, immune system cells were still infected. But they were no longer inflammatory and therefore could not contribute to damagin...
SYDNEY, March 17 (Xinhua) -- Scientists in Australia have made the world's first detailed report of how the body's immune system responds to COVID-19, describing it as similar to that of seasonal influenza. Scientists from the University of Melbourne's Peter Doherty Institute for Infection ...